| Armand Sorin Schachter, MD | |
|
2 Riverchase Ridge, Grayson & Associates Pc Suite 100, Birmingham, AL 35244 | |
| (205) 444-0420 | |
| (205) 403-0747 |
| Full Name | Armand Sorin Schachter |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 27 Years |
| Location | 2 Riverchase Ridge, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295784312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 00020958 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Grandview Medical Center | Birmingham, AL | Hospital |
| St. Vincent's East | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grayson And Associates Pc | 9032108253 | 54 |
News Archive
Rachel Cutting, Principal Embryologist at the Assisted Conception Unit at Sheffield Teaching Hospitals NHS Foundation Trust, was given the award by Health Secretary Andrew Lansley at the Chief Scientific Officer's Healthcare Science event last week.
For the study, Terry Davis of Louisiana State University and colleagues presented five common prescription drug labels to 395 low-income adults in Chicago, Ill.; Shreveport, La.; and Jackson, Miss., and asked them, "How would you take this medicine?" All participants spoke English and had no vision or hearing problems.
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
With healthcare consolidation on the rise, Craneware, Inc., the healthcare market leader in automated revenue integrity solutions, today announced that Banner Health, one of the largest not-for-profit healthcare systems in the US, has selected Craneware's Chargemaster Corporate Toolkit to support its ongoing growth and efficient integration across newly acquired facilities.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
› Verified 2 days ago
| Entity Name | Grayson And Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194772442 PECOS PAC ID: 9032108253 Enrollment ID: O20040511001342 |
News Archive
Rachel Cutting, Principal Embryologist at the Assisted Conception Unit at Sheffield Teaching Hospitals NHS Foundation Trust, was given the award by Health Secretary Andrew Lansley at the Chief Scientific Officer's Healthcare Science event last week.
For the study, Terry Davis of Louisiana State University and colleagues presented five common prescription drug labels to 395 low-income adults in Chicago, Ill.; Shreveport, La.; and Jackson, Miss., and asked them, "How would you take this medicine?" All participants spoke English and had no vision or hearing problems.
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
With healthcare consolidation on the rise, Craneware, Inc., the healthcare market leader in automated revenue integrity solutions, today announced that Banner Health, one of the largest not-for-profit healthcare systems in the US, has selected Craneware's Chargemaster Corporate Toolkit to support its ongoing growth and efficient integration across newly acquired facilities.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
› Verified 2 days ago
| Entity Name | Noahs Ark Child & Family Treatment Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093122533 PECOS PAC ID: 5890035299 Enrollment ID: O20190321002183 |
News Archive
Rachel Cutting, Principal Embryologist at the Assisted Conception Unit at Sheffield Teaching Hospitals NHS Foundation Trust, was given the award by Health Secretary Andrew Lansley at the Chief Scientific Officer's Healthcare Science event last week.
For the study, Terry Davis of Louisiana State University and colleagues presented five common prescription drug labels to 395 low-income adults in Chicago, Ill.; Shreveport, La.; and Jackson, Miss., and asked them, "How would you take this medicine?" All participants spoke English and had no vision or hearing problems.
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
With healthcare consolidation on the rise, Craneware, Inc., the healthcare market leader in automated revenue integrity solutions, today announced that Banner Health, one of the largest not-for-profit healthcare systems in the US, has selected Craneware's Chargemaster Corporate Toolkit to support its ongoing growth and efficient integration across newly acquired facilities.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Armand Sorin Schachter, MD 2 Riverchase Ridge, Grayson & Associates Pc Suite 100, Birmingham, AL 35244 Ph: (205) 444-0420 | Armand Sorin Schachter, MD 2 Riverchase Ridge, Grayson & Associates Pc Suite 100, Birmingham, AL 35244 Ph: (205) 444-0420 |
News Archive
Rachel Cutting, Principal Embryologist at the Assisted Conception Unit at Sheffield Teaching Hospitals NHS Foundation Trust, was given the award by Health Secretary Andrew Lansley at the Chief Scientific Officer's Healthcare Science event last week.
For the study, Terry Davis of Louisiana State University and colleagues presented five common prescription drug labels to 395 low-income adults in Chicago, Ill.; Shreveport, La.; and Jackson, Miss., and asked them, "How would you take this medicine?" All participants spoke English and had no vision or hearing problems.
Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."
With healthcare consolidation on the rise, Craneware, Inc., the healthcare market leader in automated revenue integrity solutions, today announced that Banner Health, one of the largest not-for-profit healthcare systems in the US, has selected Craneware's Chargemaster Corporate Toolkit to support its ongoing growth and efficient integration across newly acquired facilities.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
› Verified 2 days ago
Rayford W Thweatt, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Marla B Morgan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Robins J Newton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 400, Birmingham, AL 35205 Phone: 205-918-0507 Fax: 205-930-2716 | |
Mohamed Kazamel, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Dr. Rodney K Swillie, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 600, Birmingham, AL 35243 Phone: 205-971-3600 Fax: 844-772-0468 | |
Sandra L Frazier, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19t Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Michael Alonzo Lopez, M.D., PH.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1600 6th Ave S # Chb314, Birmingham, AL 35233 Phone: 205-996-7850 |